News
Osaka University and Otsuka Pharmaceutical Co., Ltd. entered into an exclusive, worldwide license agreement for Otsuka to use R8H283, a novel antibody that recognizes the CD98 heavy chain ...
Moderna's appetite for antibody tech spurs $6M bet on Nona's heavy chain only platform By Nick Paul Taylor Nov 11, 2022 7:30am Moderna Harbour BioMed antibody messenger RNA ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback